JPRN-UMIN000001033已完成未知
An open-label, randomized, controlled trial comparing different dosing regimens with peginterferon alpha-2a plus ribavirin in patients with chronic hepatitis C. - A randomized trial of peginterferon alpha-2a plus ribavirin for chronic hepatitis C.
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 240
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 60years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Pregnant or under breast feeding. 2. Allergic to ribavirin or other nucleoside preparations. 3. Uncontrolled cardiovascular diseases. 4. Abnormal hemoglobinemia. 5. Chronic renal failure or creatinine clearance value less than 50 mL/min. 6. Depression or psychiatric disorders. 7. Sever or decompensated liver disease. 8. Autoimmune liver diseases. 9. White blood cell count <3,000/microL, neutrophil count <1,500/microL, platelet count <90,000/microL, or hemoglobin concentration <12 g/dL. 10. Allergic to pegylated interferon alpha-2a or other interferon preparations. 11. Allergic to vaccine or biological preparations. 12. Concomitant herbal medication such as Sho-saiko-to. 13. Other conditions considered inappropriate by attending physician.
研究者
相似试验
招募中
3 期
A study to examine whether giving steroids in low dose daily is more effective than if given on alternate days, in controlling disease activity in patients with frequently relapsing nephrotic syndromeCTRI/2019/01/017091Indian Council of Medical Research
招募中
4 期
A study to compare efficacy of daily prednisolone versus standard alternate day prednisolone in patients with frequently relapsing nephrotic syndrome.CTRI/2012/12/003194Council of Scientific and Industrial Research60
进行中（未招募）
1 期
Clinical study aimed to compare tocilizumab to anti-TNF treatment and to discover biomarkers for treatment selection in rheumatoid arthritis patients with inadequate response to a first anti-TNFRHEUMATOID ARTHRITISMedDRA version: 20.0Level: LLTClassification code 10037738Term: R arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 20.0Level: LLTClassification code 10039014Term: Rh arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersMedDRA version: 23.1Level: LLTClassification code 10003268Term: Arthritis rheumatoidSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2016-001987-12-ITSOCIETA' ITALIANA DI REUMATOLOGIA - SIR208
尚未招募
4 期
An open-label randomised controlled trial comparing novel combination and currently used antibiotic regimens for the empiric treatment of neonatal sepsis with a run-in confirmatory pharmacokinetic phase: NeoSep1Neonatal DiseasesPACTR202208856270989Global Antibiotic Research and Development Partnership GARDP3,000
进行中（未招募）
1 期
A trial comparing the effect of ceftriaxone plus azithromycin versus ceftriaxone for the treatment of Neisseria gonorrhoeae on the resistance geneseisseria gonorrhoeae (Ng)MedDRA version: 21.1Level: LLTClassification code 10051970Term: Neisseria gonorrhoeae infectionSystem Organ Class: 100000004862EUCTR2021-003616-10-BEInstitute of Tropical Medicine42